Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.1500 (1.48%) ($16.8400 - $17.2000) on Tue. Aug. 6, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 58 | Latest Price | $17.1500(1.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(49%) XBI(49%) IWC(48%) | Factors Impacting HALO price | HALO will decline at least -0.815% in a week (0% probabilities). VIXM(-37%) VXX(-20%) UUP(-6%) TLT(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $17.04(0.65%) | 10 Day Moving Average | $16.93(1.3%) | 20 Day Moving Average | $16.83(1.9%) | To recent high | -3.1% | To recent low | 16.3% | Market Cap | $2.344b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |